ArticleACS central science2017
Article in ACS central science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed.
- Electrochemically driven deoxychlorination of aliphatic alcoholsChemical science · 2026Article
- Triarylselenonium triflates provide efficient access to no-carrier-addedChemical science · 2026Article
- Nitrosoarenes as Versatile Precursors forACS omega · 2026Article
- Deoxyradiofluorination of Phenols via a Difluoromethoxy Nucleofuge Enabled by Organic Photoredox Catalysis.ACS central science · 2026Article
- Article
- Distinct hydrogen atom transfer and radical capture reactivity of copper(iii) OH/F complexes enables site-selective C(spChemical science · 2026Article
- Ruthenium-MediatedJournal of the American Chemical Society · 2025Article
- Mechanochemical Sequential Deoxygenative Cross-Coupling Reactions of Phenols Under Ruthenium-Nickel Catalysis.Molecules (Basel, Switzerland) · 2025Article
- Synthesis and in vitro evaluation of spirobenzovesamicols as potentialEJNMMI radiopharmacy and chemistry · 2025Article
- Two F-18 radiochemistry methods to synthesize a promising transient receptor potential canonical 5 (TRPC5) radioligand.Journal of fluorine chemistry · 2024Article
- One-Step Synthesis of [ACS central science · 2024Article
- Ruthenium Phenoxo Complexes: An Isolobal Ligand to Cp with Improved Properties.Journal of the American Chemical Society · 2024Article
- Preparation ofPharmaceutics · 2023Article
- Deoxyfluorination of phenols for chemoselectiveNature protocols · 2023Review
- State of the art procedures towards reactive [EJNMMI radiopharmacy and chemistry · 2023Review
- Radiochemistry for positron emission tomography.Nature communications · 2023Review
- Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Recent Advances inPharmaceutics · 2022Review
- Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.European journal of medicinal chemistry · 2022Article
- Synthesis and Characterization of 5-(2-Fluoro-4-[Journal of medicinal chemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The deficiency of robust and practical methods for
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.